Navigation Links
Incisive Surgical Launches New National Patient Advocacy Campaign -- Eliminate Traumatic Metal Skin Staples for Routine Skin Closure
Date:10/5/2011

MINNEAPOLIS, Oct. 5, 2011 /PRNewswire/ -- Incisive Surgical, Inc., the maker of the revolutionary INSORB® Absorbable Skin Stapler, today announced the launch of a new national patient advocacy campaign – "Eliminate Traumatic Metal Skin Staples for Routine Skin Closure."  This campaign features a new website, www.ihatemetalskinstaples.com, which offers information regarding skin closure options available to patients undergoing surgery – metal skin staples, absorbable suture and absorbable staples.  Visitors may comment, share photos and sign a national petition.  Placing metal skin staples to close incisions is fast, but is traumatic to the patient.  Every single metal skin staple pierces and punctures the outside of the skin in two places which can result in increased pain, anxiety, and the potential of 'railroad track scars.'  Traumatic metal skin staples require removal which adds cost, inconvenience and can be painful.  Absorbable suture and absorbable staples are comprised of bioabsorbable materials and are placed entirely underneath the skin, dissolving in the body within a matter of months.  For example, Caesarean section patients typically remark that absorbable suture and absorbable staples are more comfortable and cosmetic than metal staples, and eliminate the need for post-operative removal.  Placing absorbable sutures is more time-consuming, but absorbable stapling is as fast as metal skin stapling for surgery.

"As stated in the Universal Patients' Bill of Rights, patients must have full access to and fully participate in their healthcare decisions, including the choice of skin closure methods," said John L. Shannon, Jr., president and chief executive officer of Incisive Surgical.   "We estimate that over 10,000,000 metal skin staplers are used in the United States each year.  Many patients view traumatic metal skin staples that pierce and puncture the skin as 'barbaric.' and tell their health care providers that they 'hate metal skin staples.'  In addition, traumatic metal skin staples require removal which is costly, inconvenient and can be painful.  The primary advantage of metal skin staples is speed of closure – reducing anesthesia and operating room time compared to absorbable suturing.  With the introduction of the INSORB Absorbable Skin Stapler in 2005, there is now a rapid closure technology that does not create additional injury to the patient.  Although there are some circumstances when metal skin staples may be clinically justifiable, we believe any skin closure method that pierces and punctures the skin – literally creating additional injury – is obsolete for the closure of routine surgical incisions.  Furthermore, in the more patient-centric 21st century environment, the use of traumatic metal skin staples, without first informing the patient of clinically-effective alternatives and gaining patient consent, is a clear violation of the Universal Patient's Bill of Rights."

"We measure the success of our practice by the satisfaction of our patients and our commitment to continually improve and evolve," said K. Anthony Shibley, M.D., F.A.C.O.G., Obstetrics & Gynecology Specialists, P.A., Edina, MN. (www.obgynpa.com)  "Given the improved skin closure technologies available today, I can no longer justify the use of metal skin staples for typical skin closure of surgical incisions.  Metal skin staples do cause additional injury and discomfort to the patient, and require removal.  My patients prefer absorbable skin closure methods that do not cause additional injury citing increased comfort and appearance."

"Our objectives in launching this national campaign with the new ihatemetalskinstaples.com website are to 1)  educate patients of their rights to be fully informed and to actively participate in their healthcare decisions, and 2)  to inform patients that there are now two alternatives to traumatic metal skin staples for skin closure – absorbable sutures and rapid absorbable staples," said Shannon.  "We invite visitors to the website to share their comments and photos of their incisions."

The INSORB Absorbable Skin Stapler places an absorbable staple entirely underneath the skin to close surgical incisions offering the speed of metal skin staplers with the comfort, convenience and cosmetic result of absorbable sutures.  This patented device won the prestigious 2006 Wall Street Journal Technology Innovation of the Year Award.
Incisive Surgical is the only company in the world that offers this technology and has sold over 700,000 INSORB® Skin Staplers.   For more information, visit www.insorb.com.Contact:

John L. Shannon, Jr.Ron W. McClurgIncisive Surgical, Inc.(952) 591-2543, ext. 18shannon@insorb.com
'/>"/>

SOURCE Incisive Surgical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Incisive Surgical Issued Notice of Allowance for Key Absorbable Skin Stapler Patent
2. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
3. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
4. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
5. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
6. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
7. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
8. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
9. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
10. PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
11. Early Esophageal Cancer and Pre-Cancer Eliminated With Non-Surgical Treatment Combination
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... , the only authorized OSHA Training Institute Education Center headquartered in Northern California, ... their workers from extreme heat at their worksites. Employers with workers exposed ...
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... ... , ... TherapySites, the leading website and online ... Counseling Association. This new relationship allows TherapySites to continue to extend their ... benefits and promotional offers. , "TCA is extremely excited about this new partnership, ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
Breaking Medicine News(10 mins):